{"nctId":"NCT00587769","briefTitle":"Chantix & Bupropion for Smoking Cessation","startDateStruct":{"date":"2007-07"},"conditions":["Smoking","Tobacco Use Disorder"],"count":38,"armGroups":[{"label":"Bupropion SR & Varenicline","type":"EXPERIMENTAL","interventionNames":["Drug: Bupropion SR & Varenicline"]}],"interventions":[{"name":"Bupropion SR & Varenicline","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* at least 18 years of age\n* have smoked 10 or more cigarettes per day for at least 6 months\n* are motivated to stop smoking.\n\nExclusion Criteria:\n\n* an unstable medical condition\n* unstable angina, myocardial infarction, or coronary angioplasty within the past 3 months or an untreated cardiac dysrhythmia\n* personal history of seizures\n* closed head trauma with any loss of consciousness or amnesia in the last 5 years\n* ever history of closed head trauma with \\> 30 minutes of loss of consciousness or amnesia or resulting in skull fracture or subdural hematoma/brain contusion\n* a history or psychosis, bipolar disorder, bulimia or anorexia nervosa)\n* have current depression as assessed by Center for Epidemiologic Studies Depression (CES-D)\n* have active substance abuse other than nicotine\n* have used an investigational drug within the last 30 days\n* are currently using a behavioral or pharmacologic tobacco treatment and unwilling or unable to discontinue use\n* use of bupropion or varenicline in the previous 3 months\n* current (past 14 days) use of antipsychotic or antidepressant\n* an allergy to bupropion or varenicline\n* untreated hypertension or baseline systolic blood pressure \\> 180 or diastolic \\> 100\n* have another member of their household already participating in this study.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Point Prevalence Smoking Abstinence at 12 Weeks: the Number of Patients Who Refrained From Smoking at 12 Weeks","description":"Smoking abstinence biochemically confirmed with exhaled carbon monoxide concentrations","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null}]}]}]},{"type":"SECONDARY","title":"Point Prevalence Smoking Abstinence at 6 Months: the Number of Patients Who Refrained From Smoking at 6 Months","description":"Smoking abstinence biochemically confirmed with exhaled carbon monoxide concentrations","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":38},"commonTop":["Sleep disturbance","Nausea","Insomnia","Dizziness","Vivid dreams"]}}}